% | $
Quotes you view appear here for quick access.

VPHM Message Board

  • nuhawkus nuhawkus Jan 21, 2013 10:48 AM Flag


    I really believe Zacks is intent on holding VPHM's share price down for some reason. Every time VPHM gets some good press i.e. 2013 guidance or Bank of America upgrade, Zacks comes out with some negative comment and pushes Valeant Pharm. Have you looked at Valeant? Poor EPS and high PE. Looks way overpriced. Guess it is no big deal but looks curious to me.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • funny I have the same impression, they came out with basically the same article twice, one after the 2013 guidance and now after Bank of America ups to a buy recommendation... Waaaat gives?

      they are in sharp contrast to the bigger analysts that are issuing favorable recommendations and raising their price targets... recent ones include WallachBeth(28), Leerink Swan(30), Bank of America(33), Oppenheimer(36), Deutsche Bank(37), JeffriesGroup(40), Wells Fargo, ....